CNBCLean R·
Novo defends diversification push as CEO eyes deals beyond obesity
Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.
Read at CNBC →
Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.
<iframe src="https://statesidedaily.com/embed/cluster/aa6fd47addb9876985df256e3515f78bab7bf6d6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novo defends diversification push as CEO eyes deals beyond obesity"></iframe>